Yuqin Song, MD
Peking University Cancer Hospital & Institute
4
4
0
N/A
0
4
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (4)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Jun Zhu, MD
Peking University Cancer Hospital & Institute
Shared therapeutic areas:
Worked with same sponsors:
Beata Holkova, MD
Massey Cancer Center
Shared therapeutic areas:
Eliot Epner, MD
Penn State Hershey Cancer Institute
Shared therapeutic areas:
Maria Delioukina, MD
City of Hope National Medical Center, USA
Shared therapeutic areas:
Peter Brown, MD
H:S Rigshospitalet, Department of Hematology, Denmark
Shared therapeutic areas:
Madeleine Duvic, MD
UT - M. D. Anderson Cancer Center
Shared therapeutic areas:
Fernando Camacho, MD
Bronx River Medical Associates, PC
Shared therapeutic areas:
Andrei Shustov, MD
Fred Hutchinson Cancer Research Center - Seattle Cancer Care Alliance
Shared therapeutic areas:
Andreas Neubauer, MD
University Hospital Marburg, Marburg, Germany
Shared therapeutic areas:
Adam Lerner, MD
Boston Medical Center, USA
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (4)
Showing 4 of 4 trials
Phase I Clinical Study of JS203 in Patients With Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma
A Study of PD-1/CTLA-4 Bispecific AK104 in Relapsed or Refractory Peripheral T-cell Lymphoma
Study of GLS-010 Injection in the Treatment of Classical Hodgkin's Lymphoma
A Phase III Study to Evaluate the Efficacy and Safety of Penpulimab in the Relapsed and Refractory Classical Hodgkin's Lymphoma
All 4 trials loaded